Cargando…
Identification of Gefitinib Resistance-Related lncRNA-miRNA-mRNA Regulatory Networks and Corresponding Prognostic Signature in Patients with Lung Adenocarcinoma
PURPOSE: To identify and characterize gefitinib resistance-related (GefR-related) lncRNAs and construct a prediction model for lung adenocarcinoma (LUAD). METHODS: Differential expression analysis between PC9 and gefitinib-resistant PC9 (PC9GR) cell samples was performed to screen GefR-related lncRN...
Autores principales: | Wang, Taoli, Wu, Zhulin, Li, Shiguang, Chen, Zhong, Chen, Yiqi, Yang, Zhenjiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477152/ https://www.ncbi.nlm.nih.gov/pubmed/36118184 http://dx.doi.org/10.2147/IJGM.S369718 |
Ejemplares similares
-
Integrated Dissection of lncRNA-miRNA-mRNA Pairs and Potential Regulatory Role of lncRNA PCAT19 in Lung Adenocarcinoma
por: Tang, Xiaomei, et al.
Publicado: (2022) -
Prognostic lncRNA, miRNA, and mRNA Signatures in Papillary Thyroid Carcinoma
por: Wang, Kun, et al.
Publicado: (2020) -
Construction of chronic glomerulonephritis‑related lncRNA‑mRNA regulatory network and lncRNA‑miRNA‑mRNA ceRNA network by bioinformatics analysis
por: Zhuang, Xing-Xing, et al.
Publicado: (2023) -
An Integrated Analysis of miRNA, lncRNA, and mRNA Expression Profiles
por: Guo, Li, et al.
Publicado: (2014) -
Identification and validation of potential mRNA- microRNA- long-noncoding RNA (mRNA-miRNA-lncRNA) prognostic signature for cervical cancer
por: Wang, Jie, et al.
Publicado: (2021)